- Upcoming IPOs (Sep 1–14, 2025)
- What each company does, at a glance
- Simple 5-point application test
- Ground rules (lot size, anchors, SME specifics)
The short
- Line-up: 7 issues on the radar for Sep 1–14 — 1 mainboard (Amanta Healthcare) and 6 SME (Rachit Prints, Optivalue Tek Consulting, Goel Construction Company, Austere Systems, Vigor Plast India, Sharvaya Metals).
- How to screen fast: Run our 5-point test first — use of proceeds, customer concentration, cash conversion, governance hygiene, and avoid GMP-chasing.
- Retail basics: SME lots are larger and post-listing liquidity can be thin. Use limit orders; approve the UPI mandate promptly after applying.
- Signals that matter: Anchor book quality and Day-2 QIB traction > social buzz. Prefer growth/capex-heavy issues to pure OFS.
- Action: Set reminders for open/close days. If the checklist isn’t comfortably green, skip — sitting out is a valid position.
Opening windows (Sep 1–14)
| Company | Segment | Opens → Closes | Price band (₹) | What it does |
|---|---|---|---|---|
| Amanta Healthcare | Mainboard | Sep 1 → Sep 3 | 120–126 | Sterile liquid formulations: IV fluids, ophthalmic & respiratory solutions; capex for new lines. |
| Rachit Prints | SME | Sep 1 → Sep 3 | 140–149 | Speciality fabric printing & processing. |
| Optivalue Tek Consulting | SME | Sep 2 → Sep 4 | 80–84 | IT consulting & services; fresh issue for growth. |
| Goel Construction Company | SME | Sep 2 → Sep 4 | 249–262 | Construction contracting & allied services. |
| Austere Systems | SME | Sep 3 → Sep 8 | 52–55 | IT solutions/services; BSE SME listing expected. |
| Vigor Plast India | SME | Sep 4 → Sep 9 | 77–81 | Plastic moulded products; NSE SME listing expected. |
| Sharvaya Metals | SME | Sep 4 → Sep 9 | 192–196 | Aluminium products manufacturer. |
Note Tentative listing timelines cluster around Sep 10–12 for the SME cohort; check broker/platform pages for daily updates during the week.
5-point “Should I apply?” test (no P/E maths)
- Use of proceeds: Prefer issues where majority of funds go to growth capex/working capital over heavy promoter OFS.
- Customer/segment concentration: Avoid stories overly reliant on a single customer, tender, or cyclical end-market.
- Cash conversion: Scan FY24–FY25 commentary for high receivables or inventory build-ups relative to sales — red flag for cash generation.
- Governance hygiene: Related-party transactions should be ordinary-course and shrinking; promoter pledges should be nil/low.
- Market heat ≠ quality: Don’t chase grey-market chatter. Anchor book quality, QIB participation by Day-2, and sensible lot sizing matter more.
Quick practice Skim the RHP/PR for “Objects of the Issue”, “Risk Factors”, and “Related Party Transactions” first. If these feel uncomfortable, skip — regardless of GMP.
Ground rules (fast)
- Lot sizes & SME quirks: SME IPOs often have larger minimum lots; liquidity post-listing can be thin; use limit orders.
- Anchor/QIB signals: Quality institutions and sensible allocation are more meaningful than social-media buzz.
- Checklist discipline: Apply only where your 5-point test is comfortably green. Sitting out is a position.